Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.51817 | 72 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.45436 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.46681 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.3395 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.31943 | 70 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.21492 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.47207 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.45094 | 71 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.62831 | 72 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.36849 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.42213 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.34029 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.48239 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.45421 | 71 |